arrow_rightarrow_righticon_excelicon_pficon_ppticon_wordmagnifier

SUNDAY 13 OCTOBER 2019

Sunday 13 Oct

Meet the expert sessions

08:00

M06 Hematology - hematopoietic stem cell transplantation

Nikolai Klimko, FECMM, Russia & Tony Pagliuca, United Kingdom

08:00

M07 Molecular diagnostics

Maurizio Sanguinetti, Italy & Dieter Buchheidt, FECMM, Germany

08:00

M08 Surgery / transplantation

Patricia Munoz, Spain & Paolo Grossi, Italy

08:00

M09 Neonates

Thomas Walsh, FECMM, USA & Emmanuel Roilides, FECMM, Greece

08:00

M10 Meet Mr. and Mrs. Fungus

Cornelia Lass-Flörl, FECMM, Austria & Neil Gow, FECMM, UK

08:50

Plenary session 4 - Top 10 papers in Mycology

08:50

PS4.1 - The clinical and translational perspective

Don Sheppard, FECMM, Canada

09:20

PS4.2 - The microbiology perspective

Katrien Lagrou, FECMM, Belgium

ECMM Academy and Excellence Centers: A story of success

09:50

ECMM Academy

Katrien Lagrou, FECMM, Belgium

09:55

ECMM Excellence Centers

Cornelia Lass-Flörl, FECMM, Austria

10:00

Coffee break

10:30

Plenary session 5 - ICU - candida infections / Breaking news from Hematology and ICU

10:30

PS5.1 Peritonitis

10:45

PS5.2 Are the new management strategies useful?

Arnaldo Colombo, FECMM, Brazil

11:00

PS5.3 CNS infections

Anna Candoni, Italy

11:15

PS5.4 CMV and aspergillosis in HSCT patients

Johan Maertens, FECMM, Belgium

11:30

Poster session 2

Video session

11:30

V01

11:40

V02

11:50

V03

12:30

Lunch

12:30

Sponsored Diagnostic Symposium

More information on www.timm2019.org/sponsored-symposia

13:00

Sponsored Integrated Symposium 4

More information on www.timm2019.org/sponsored-symposia

14:15

Parallel Symposia 15-19

Symposium 15 Aspergillus in the ICU

14:15

S15.1 Influenza

Joost Wauters, Belgium

14:35

S15.2 Invasive aspergillosis in patients with underlying liver cirrhosis

Juergen Prattes, Austria

14:55

S15.3 Renal failure

Riina Richardson Rautema, FECMM, United Kingdom

15:15

S15.4* Fungal pneumonia in critically ill cirrhotics: Spectrum, Outcomes, Comparison of diagnostic methods and Biomarkers

Pratibha Kale, India

15:25

S15.5* IPAFLU survey: Invasive Aspergillosis among Patients with Severe Influenza in Intensive Care Units

Joost Wauters, Belgium

15:35

S15.6* Trend of Candidemia with Bloodstream infection in Intensive care units from 2006 to 2017: Results from the Korean National Healthcare-associated Infections Surveillance System

Young Hwa Choi, Republic of Korea

Symposium 16 Dermatology

14:15

S16.1 Cutaneous aspergillosis, is it so rare?

Sevtap Arıkan Akdagli, FECMM, Turkey

14:35

S16.2 Is resistance a problem for dermatophytosis?

Pietro Nenoff, Germany

14:55

S16.3 Phaeohyphomycosis

Teresa Martin, Spain

15:15

S16.4 Blastomycosis

Ilan Schwarz, Canada

15:35

S16.5* Galleria mellonella as a novelty model to study host – pathogen interaction in Malassezia furfur CBS 1878

Adriana Marcela Celis Ramírez, Colombia

Symposium 17 HIV associated cryptococcal meningitis

14:15

S17.1 Screening in low-resource areas

Elvis Temfack, Cameroon

14:35

S17.2 Current therapeutic strategies

Olivier Lortholary, France

14:55

S17.3 Towards having antifungal drugs in low-resource areas

Angela Loyse, United Kingdom

15:15

S17.4 Early versus delayed antiretroviral treatment in HIV-positive people with cryptococcal meningitis

Tihana Bicanic, FECMM, United Kingdom

15:35

S17.5 Current and future clinical trials on HIV-associated cryptococcal meningitis

Tom Harrison, United Kingdom

Symposium 18 Antifungal stewardship in the era of resistance

14:15

14:15

S18.1 Antifungal stewardship: a practical experience in a tertiary care institution

Maricela Valerio, Spain

14:35

S18.2 Stewardship and azole resistant aspergillosis: a challenge for farmer or physician?

Paul Verweij, FECMM, the Netherlands

14:55

S18.3 Rapid diagnosis of fungal infections: Impact on stewardship

Souha Kanj, FECMM, Lebanon

15:15

S18.4 Mycology laboratory diagnostic capabilities in different areas of the world

Alessandro Pasqualotto, FECMM, Brazil

15:35

S18.5* Optimising antifungal stewardship: An evaluation of candidaemia guideline compliance and clinical outcome

Laura Cottom, United Kingdom

Symposium 19 Pneumocystis

14:15

S19.1 Diagnosis

Alexandre Alanio, FECMM, France

14:35

S19.2 Pneumocystosis and HIV

Joseph Kovacs, USA

14:55

S19.3 Pneumocystosis in non-HIV patients

15:15

S19.4 Pneumocystosis in neonates

Enrique Calderon, Spain

15:35

S19.5* Evaluation of a novel commercial Loop-mediated Isothermal Amplification (LAMP) assay for rapid detection of Pneumocystis jirovecii

Dirk Schmidt, Germany

15:45

Coffee break

16:15

Parallel Symposia 20-24

Symposium 20 Candida auris

16:15

S20.1 Schizophrenic gram negative yeast conquering the world

Jacques Meis, FECMM, the Netherlands

16:35

S20.2 In the US

Tom Chiller, USA

16:55

S20.3 Outbreak control

Alba Ruiz, Spain

17:15

S20.4 In resource limited countries

Anuradha Chowdhary, FECMM, India

17:35

S20.5* Understanding Echinocandin Activity Towards Candida auris

Milena Kordalewska, USA

Symposium 21 Immunotherapy for opportunistic fungal infections

16:15

S21.1 CAR-T cells, NK cells

Dimitrios Kontoyiannis, FECMM, USA

16:35

S21.2 WBC transfusions

Livio Pagano, FECMM, Italy

16:55

S21.3 Cytokines

George Chamilos, Greece

17:15

S21.4* Novel chimeric antigen receptor T cells for invasive aspergillosis immunotherapy

Michelle Seif, Germany

17:25

S21.5* Comparison of circulating lymphocyte populations CD4+ and CD8+ T cells, B and NK lymphocytes according to the favorable or worsening evolution of patients with pneumocystosis

Eléna Charpentier, France

17:35

S21.6* Glucosylceramides from Lomentospora prolificans Induce Cytokines Production and Increase the Microbicidal Activity of Macrophages

Mariana Ingrid Dutra Silva Xisto, Brazil

Symposium 22 NGS and mycobiota

16:15

S22.1 Bacterial-fungal interactions at the airway mucosa and implications for chronic rhinosinusitis

Emily Cope, USA

16:35

S22.2 Respiratory mycobiome – a clinical perspective

Robert Krause, FECMM, Austria

16:55

S22.3 Characterization of indoor dust microbiota in homes of asthma and non asthma patients

Jean-Pierre Gangneux, FECMM, France

17:15

S22.4 Understanding the role of the gut mycobiome in health and disease

Maria Vehreschild, FECMM, Germany

17:35

S22.5* An ECMM-ESCMID survey on goals and practices for mycobiota characterization using Next Generation Sequencing in European laboratories

Jean-Pierre Gangneux, FECMM, France

Symposium 23 The funny life of C. albicans in the oral tract

16:15

S23.1 Within-host genomic diversity of Candida albicans in healthy carriers.

Marie-Elisabeth Bougnoux, France

16:35

S23.2 Activation oral immune responses by C. albicans

Julian Naglik, UK

16:55

S23.3 Modulation of the fungal-host interaction by the intra-species diversity of C. albicans

Dominique Sanglard, Switzerland

17:15

S23.4 Intestinal Th17 drives airway inflammation in ABPA

Petra Bacher, Germany

17:35

S23.5* Persistence of clonal azole-resistant isolates of Candida albicans from a patient with Chronic Mucocutaneous Candidiasis in Colombia

Andres Ceballos-Garzon, Colombia

Symposium 24 Fungal Neglected Tropical Diseases

16:15

S24.1 Mycetoma

Wendy van de Sande, FECMM, the Netherlands

16:35

S24.2 Chromoblastomycosis

Flavio de Queiroz-Telles, FECMM, Brazil

16:55

S24.3 Sporotrichosis

Leila Lopes Bezerra, Brazil

17:15

S24.4 Novel diagnostic and treatment strategies for the Southeast Asian fungus Talaromyces marneffei

Thuy Le, USA

17:25

S24.5* Urban sporotrichosis: neglected micro-epidemia in the State of Minas Gerais, Brazil

Maria Aparecida Resende Stoianoff, Brazil

Ben De Pauw Lectures (EORTC)

Johan Maertens

Belgium

Thierry Calandra

Switzerland

19:30

Congress dinner